Management ChangeMay 15, 2026, 04:10 PM
C4 Therapeutics Appoints CFO Adams as Principal Accounting Officer
AI Summary
C4 Therapeutics announced a change in its principal accounting officer role. Mark Mossler will no longer serve as Chief Accounting Officer, effective May 15, 2026, a departure not due to any disagreements. Kendra R. Adams, the company's Chief Financial Officer, Head of Corporate Affairs, and Treasurer, has been designated as the new principal accounting officer, effective the same date. Ms. Adams will not receive additional compensation for this expanded role.
Key Highlights
- Mark Mossler will no longer serve as C4 Therapeutics' Chief Accounting Officer, effective May 15, 2026.
- Mr. Mossler's departure is not due to any disagreement with the company.
- Kendra R. Adams, the company's CFO, Head of Corporate Affairs, and Treasurer, is designated as the new principal accounting officer.
- Ms. Adams' appointment as principal accounting officer is effective May 15, 2026.
- Ms. Adams will not receive any additional compensation for assuming the principal accounting officer role.
Price Impact
More from CCCC